Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies. [electronic resource]
- Vascular health and risk management Apr 2010
- 179-87 p. digital
Publication Type: Journal Article
1178-2048
10.2147/vhrm.s6099 doi
Acute Coronary Syndrome--drug therapy Anticoagulants--adverse effects Catheterization--adverse effects Enoxaparin--therapeutic use Fondaparinux Hirudins Humans Peptide Fragments--therapeutic use Polysaccharides--adverse effects Recombinant Proteins--therapeutic use Thrombosis--etiology